Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
Ashish Pemawat, Associate Director of Institute of Neurosciences, shared on LinkedIn about a recent article by Ahmet Günkan et al, published in Stroke, adding:
”Is the 4.5-hour thrombolysis window becoming less relevant?
A recent meta-analysis published in Stroke (2025) pooled data from 8 randomized controlled trials involving 1,742 patients with acute ischemic stroke treated beyond the conventional 4.5-hour window.
Intravenous thrombolysis increased the odds of:
- Excellent functional outcome (mRS 0–1): OR 1.43
- Functional independence (mRS 0–2): OR 1.36
Additional benefits included higher rates of recanalization, reperfusion, and early neurological improvement.
As expected, symptomatic intracerebral hemorrhage was more frequent (OR 4.25), but importantly, there was no statistically significant increase in 90-day mortality.
The key message is clear: patient selection matters more than the clock.
Advanced imaging techniques—particularly perfusion imaging and DWI-FLAIR mismatch—can identify salvageable brain tissue and safely expand access to thrombolysis for selected patients presenting well beyond 4.5 hours or with wake-up stroke.
As stroke care continues to evolve, the paradigm is increasingly shifting from a rigid time-window approach toward a tissue-window approach, allowing more patients to benefit from reperfusion therapy.”
Title: Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials
Authors: Ahmet Günkan, Marcio Yuri Ferreira, Marina Vilardo, Luca Scarcia, Jhon E. Bocanegra-Becerra, Leonardo Januario Campos Cardoso, Luis F. Fabrini Paleare, Gustavo de Oliveira Almeida, Gabriel Semione, Christian Ferreira, Gabriele Ciccio, Adnan Mujanovic, Pascal Jabbour, Yafell Serulle, Thanh N. Nguyen, Jean-Claude Baron
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together
-
Jun 7, 2026, 18:24Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
-
Jun 7, 2026, 18:21Gulab Makwana: Complete Guide to Clotting Factors – Understanding the Coagulation System
-
Jun 7, 2026, 18:15Chuhan Dong: Presenting My Research on Antibody-Mediated RBC Clearance at Canadian Blood Services
-
Jun 7, 2026, 18:11Abdul Mannan: Pencil Cells in IDA – Why Most, but Not All Cases Show Them
-
Jun 7, 2026, 16:12Amr Mohamed: Common Types of Anemia
-
Jun 7, 2026, 15:50Venkateshwarlu Bairi: AVEVA Hyderabad Supports Children Living with Thalassemia and Sickle Cell Conditions
-
Jun 7, 2026, 15:48José Antonio García Erce: Hemochromatosis and Blood Donation